Ben Nicholas

This study identifies a ubiquitous neoantigen-reactive T-cell response across multiple metastatic sites in a patient with pancreatic neuroendocrine tumor, supporting the use of mutation-sharing status for neoantigen selection in immunotherapy.

The paper identifies functional neoantigens in NSCLC patients using immunopeptidomics, achieving an 83% success rate in eliciting immune responses.

This paper identifies 19 ZIKV peptides presented on paediatric brain tumour cells via HLA-I, showing their potential for developing epitope-specific immunotherapies.

This study compares protein expression between oesophageal adenocarcinoma and normal adjacent tissue using proteomics to identify differentially expressed proteins and pathways.

The paper compares transcriptomic and proteomic expression between two NSCLC subtypes to identify potential therapeutic targets and biomarkers.